MetaCap

ASP Isotopes Inc. (ASPI)

NASDAQ: ASPIIndustrialsMajor ChemicalsUSD

1.10-0.035 (-3.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ASPI stock chart

Technical analysis

Key statistics

All statistics
Market cap
$171.42M
EPS (TTM)
-$1.55
52-week range
1.03 – 8.60
Day range
1.03 – 1.17
Volume / Avg
8.95M / 4.45M
Beta
—

52-week range

$1.03$8.60

ASPI stock today

ASP Isotopes (ASPI) closed at $1.10 on Nov 20, down 3.08% (-$0.035), versus the S&P 500's 3.70% decline. Volume was 2.0x the average at 8.95M shares, a sign of unusually heavy trading. Shares are 87.2% below their 52-week high of $8.60, set on Jan 23, 2026 and 6.8% above the 52-week low of $1.03, near the bottom of the past year's range.

ASPI is down 79.4% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 81.6%. ASP Isotopes has posted a net loss over the last twelve months (EPS of -$1.55), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About ASP Isotopes

Company profile

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market.

Industry
Major Chemicals
CEO
Mr. Paul Elliot Mann C.F.A.
Headquarters
Dallas, TX
Employees
271
IPO year
2022

Financial highlights

Full financials

In fiscal 2025, ASP Isotopes generated $23.8 million in revenue, up 475.5% from fiscal 2024, its 3rd consecutive year of revenue growth. ASP Isotopes reported a net loss of $159.8 million, compared with a loss of $32.4 million a year earlier. Gross margin was 14.3% (down from 38.6%) and operating margin -251.2%.

ASP Isotopes annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022
Revenue$23.85M$4.14M$433.03K$0
Growth+475.51%+856.99%——
Net income$-159.84M$-32.42M$-16.29M$-4.95M
EPS (diluted)$-2.11$-0.63$-0.49—

Analyst forecast

Forecast

Consensus (3 analysts)

none

Avg. price target

$13.00+1081.82%

  • Strong buy 0
  • Buy 3
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $11.00High $15.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 18, 2026
EPS actual vs est.
$-0.21 vs —

ASPI news

All ASPI news

ASP Isotopes peers

Industrials sector
ASPI peer companies
CompanyPrice% ChgMarket capCompare
OECOrion S.A.3.13-3.99%$176.50Mvs ASPI
FFFutureFuel Corp.2.93-2.33%$128.52Mvs ASPI
LTBRLightbridge Corporation3.24-9.13%$125.40Mvs ASPI
ARQArq Inc.2.82-3.42%$124.61Mvs ASPI
ACNTAscent Industries Co.12.42-0.88%$112.05Mvs ASPI
ALTOAlto Ingredients Inc.2.98-3.25%$231.16Mvs ASPI
TROXTronox Holdings plc1.45-11.59%$231.57Mvs ASPI
CDXSCodexis Inc.1.01-3.81%$110.69Mvs ASPI

Indexes, lists and sector

ASP Isotopes stock FAQ

What is ASP Isotopes's stock price today?

ASPI last traded at $1.10 as of Nov 20, 4:00 PM EST, down 3.08% on the day. Prices are delayed at least 15 minutes.

Who is ASP Isotopes's CEO?

Mr. Paul Elliot Mann C.F.A. is the chief executive officer of ASP Isotopes Inc., which has about 271 employees.

What is the ASPI 52-week high?

The 52-week high for ASPI is $8.60 and the 52-week low is $1.03. The stock is currently 87.2% below its high.

Compare ASPI